Last reviewed · How we verify
Botulinum toxin injected into trigone
At a glance
| Generic name | Botulinum toxin injected into trigone |
|---|---|
| Also known as | Botulinum toxin, Onabotulinumtoxin, Botox |
| Sponsor | Mr HD Flood |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial (NA)
- Comparing Treatments for Refractory Overactive Bladder: Bladder Denervation vs Botulinum Toxin Injections (PHASE4)
- Transvaginal Botulinum Toxin A for Interstitial Cystitis / Bladder Pain Syndrome (EARLY_PHASE1)
- Botox for Neurogenic Detrusor Overactivity and the Prevention of Autonomic Dysreflexia Following SCI (PHASE4)
- Intravesicular Onabotulinumtoxin A in Interstitial Cystitis (PHASE4)
- Botulinum Toxin in the Treatment of Idiopathic Detrusor Overactivity (PHASE4)
- Intravesical Injection of Botulinum Toxin A Versus Saline for Neurogenic Detrusor Overactivity (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Botulinum toxin injected into trigone CI brief — competitive landscape report
- Botulinum toxin injected into trigone updates RSS · CI watch RSS
- Mr HD Flood portfolio CI